Comparison of Pathologic Complete Response Rates and Oncologic Outcomes in Patients With Surgically Resectable Esophageal Cancer Treated With Neoadjuvant Chemoradiation to 50.4 Gy vs 41.4 Gy

Background Excellent outcomes and high rates of pathologic complete response (pCR) have been reported in patients with operable esophageal carcinoma using 41.4 Gy of radiation with concurrent carboplatin and paclitaxel. With pCR rates similar to studies using higher doses, it remains unclear whether...

Descripción completa

Detalles Bibliográficos
Autores principales: Nehlsen, Anthony D, Lehrer, Eric J, Resende-Salgado, Lucas, Rosenzweig, Kenneth E, Buckstein, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Radiation Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641694/
https://www.ncbi.nlm.nih.gov/pubmed/34877210
http://dx.doi.org/10.7759/cureus.19233

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641694/
https://www.ncbi.nlm.nih.gov/pubmed/34877210
http://dx.doi.org/10.7759/cureus.19233

Ejemplares similares